Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from National Medical Products Administration (NMPA) for the ...
Good morning, and welcome to PennantPark Floating Rate Capital's fourth-fiscal quarter 2024 earnings conference call. Today's conference is being recorded. (Operator Instructions) This is -- it is now ...